Octapharma USA hires former Baxter BioScience executive

David Holliday appointed VP commercial development
January 12, 2012
Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>
Related Terms:
Branded
People in the News
Pharmacist Society
Collaborative Care
Supplier News
Latest News
Specialty Pharmacy
Pharmacy
Octapharma AG
Employment Change
Baxter Bioscience
Biology
Blood
Blood disorders
Coagulation
Coagulation system
David Holliday
executive
Genetic disorders
Haemophilia
Hematology
Medicine
New Jersey
Von Willebrand disease
Von Willebrand factor
Willebrand
© 2012 Drug Store News. All Rights Reserved.